Resistance to chemotherapy: What are the risks for the reindeer industry?

Authors

  • P. J. Waller CSIRO Division of Animal Health, McMaster Laboratory, Private Bag No. 1, Glebe, NSW 2037, Australia. Present Address: The Royal Veterinary and Agricultural University, Institute of Microbiology and Hygiene, 13, Bulowsvej, DK-1870 Frederiksberg C. Phone: 3

DOI:

https://doi.org/10.7557/2.10.4.905

Keywords:

reindeer, chemotherapy, drug resistance, anthelmintics,

Abstract

Although no drug resistance has been reported so far for parasites of reindeer, it would be unwise to assume that this situation will remain the same indefinitely. It is important to consider the principles of selection for resistance and plan ways of limiting these so that the emergence of resistance can be avoided.

Downloads

Published

1990-09-01

How to Cite

Waller, P. J. (1990). Resistance to chemotherapy: What are the risks for the reindeer industry?. Rangifer, 10(4), 14–18. https://doi.org/10.7557/2.10.4.905

Issue

Vol 10 (1990): Special Issue No. 4

Section

Articles

License